TY - JOUR
T1 - Prevention effect of 5-fluorouracil natural delayed-release microballoons on proliferative vitreoretinopathy
AU - Chen, Xiao
AU - Qin, Shuai
AU - Fu, Xu Dong
AU - Ding, Qin
PY - 2011/6/1
Y1 - 2011/6/1
N2 - Background: Proliferative vitreoretinopathy (PVR) is a tissue repair prevention and treatment of PVR in clinic. Natural delayed release microballoons are therefore becoming a hot spot for its easy manipulation, large lading dose and long acting duration. Objective: This study was to evaluate the effect of 5-fluorouracil natural delayed release microballoons on the prevention of PVR. Methods: The lymphocytes were collected from clean pigment rabbit to prepare the 8×10 7/ml cell suspension with complete culture fluid. PVR models were established in 45 healthy pigment rabbits by intravitreal injection of lymphocyte suspension. The animals were randomly divided into 3 groups and 15 rabbits for each. 0.1 ml normal saline, 10 g/L or 20 g/L 5-fluorouracil natural delayed release microballoons were injected into vitreous cavity respectively. PVR was graded on Fastenberg' s method under the slit lamp in 1, 2, 4, 8 weeks. The animals were sacrificed and retinas were obtained for the histopathological and ultrastructural examination in the eighth week after administration of drug. Results: The numbers of eyes with different grades of PVR were significantly different among 3 groups in 1 week, 2, 4, 8 weeks (P<0.05). The eye numbers with PVR was significant less in 20 g/L Fu group than those of 10 g/L Fu group and normal saline group (P<0.05). There was statistical difference in PVR ranking among these 3 groups in 8 weeks after injection of drug (H=46.795, P<0.05). The morphology and ultrastructure of retinas under the light microscope and transmission electron microscope were near normal in all of the three groups. Conclusion: Implantation of 5-fluorouracil natural delayed release microballoons into vitreous cavity is effective and safe in preventing PVR in experimental model, and the therapeutic effect of microballoons with 20 g/L 5-Fu is better.
AB - Background: Proliferative vitreoretinopathy (PVR) is a tissue repair prevention and treatment of PVR in clinic. Natural delayed release microballoons are therefore becoming a hot spot for its easy manipulation, large lading dose and long acting duration. Objective: This study was to evaluate the effect of 5-fluorouracil natural delayed release microballoons on the prevention of PVR. Methods: The lymphocytes were collected from clean pigment rabbit to prepare the 8×10 7/ml cell suspension with complete culture fluid. PVR models were established in 45 healthy pigment rabbits by intravitreal injection of lymphocyte suspension. The animals were randomly divided into 3 groups and 15 rabbits for each. 0.1 ml normal saline, 10 g/L or 20 g/L 5-fluorouracil natural delayed release microballoons were injected into vitreous cavity respectively. PVR was graded on Fastenberg' s method under the slit lamp in 1, 2, 4, 8 weeks. The animals were sacrificed and retinas were obtained for the histopathological and ultrastructural examination in the eighth week after administration of drug. Results: The numbers of eyes with different grades of PVR were significantly different among 3 groups in 1 week, 2, 4, 8 weeks (P<0.05). The eye numbers with PVR was significant less in 20 g/L Fu group than those of 10 g/L Fu group and normal saline group (P<0.05). There was statistical difference in PVR ranking among these 3 groups in 8 weeks after injection of drug (H=46.795, P<0.05). The morphology and ultrastructure of retinas under the light microscope and transmission electron microscope were near normal in all of the three groups. Conclusion: Implantation of 5-fluorouracil natural delayed release microballoons into vitreous cavity is effective and safe in preventing PVR in experimental model, and the therapeutic effect of microballoons with 20 g/L 5-Fu is better.
KW - 5-Fluorouracil
KW - Delayed release microballoons
KW - Proliferative vitreoretinopathy
UR - http://www.scopus.com/inward/record.url?scp=84862067600&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862067600&partnerID=8YFLogxK
U2 - 10.3760/cma.j.issn.2095-0160.2011.06.005
DO - 10.3760/cma.j.issn.2095-0160.2011.06.005
M3 - Article
AN - SCOPUS:84862067600
SN - 2095-0160
VL - 29
SP - 501
EP - 504
JO - Zhonghua Shiyan Yanke Zazhi/Chinese Journal of Experimental Ophthalmology
JF - Zhonghua Shiyan Yanke Zazhi/Chinese Journal of Experimental Ophthalmology
IS - 6
ER -